897316

Acella Pharmaceuticals, LLC — FEI 3006691461

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Alpharetta, GA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)